PIK3CA encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase and is one of the genes frequently altered in endometrial carcinoma, with potential consequences for PI3K/AKT/mTOR signaling. This study aimed to characterize the somatic mutation landscape of PIK3CA and evaluate its association with histological types of endometrial carcinoma using data from the TCGA-UCEC PanCancer Atlas. This was an observational analytical secondary analysis with a cross-sectional design using publicly available genomic and clinicopathological data from the 2018 TCGA-UCEC PanCancer Atlas through cBioPortal. The unit of analysis was the tumor sample. PIK3CA mutation status, histological type, mutation type, protein alteration, and the number of mutations per sample were analyzed. Samples classified as not profiled were not considered wild-type and were excluded from the mutation-status analysis. The association between histological type and mutation status was assessed using Pearson’s chi-square test, Cramér’s V, and crude odds ratios (ORs) with 95% confidence intervals (CIs). Of the 529 initial samples, 517 were evaluable, comprising 388 endometrioid, 108 serous/papillary serous, and 21 mixed endometrial carcinoma samples. Somatic PIK3CA mutations were identified in 259 samples (50.1%). Among the available data, 377 alteration events were recorded and currently classified in the mutation table, with missense mutations being the predominant category (357 events; 94.7% based on the initial calculation). The most frequently recurrent mutations were R88Q, H1047R, E542K, and E545K. Among the 259 mutated samples, 83 (32.0%) harbored more than one PIK3CA mutation event. The mutation frequency was higher in endometrioid (53.6%) and mixed (52.4%) carcinomas than in serous/papillary serous carcinoma (37.0%). A significant association was observed between histological type and PIK3CA mutation status (χ² = 9.326; df = 2; p = 0.009; Cramér’s V = 0.134). The odds of PIK3CA mutation in endometrioid carcinoma were 1.96 times those in serous/papillary serous carcinoma (95% CI, 1.27–3.05; p = 0.003). PIK3CA mutations are common molecular alterations in the TCGA-UCEC dataset and are predominantly represented by missense changes, with several recurrent variants affecting residues R88, E542, E545, and H1047. PIK3CA mutation status shows a differential distribution across histological types, with a higher mutation frequency in endometrioid carcinoma than in serous/papillary serous carcinoma.
Copyrights © 2026